WallStreetZenWallStreetZen

NASDAQ: SXTP
60 Degrees Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
60 Degrees Pharmaceuticals revenue was $627.40k for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was -$465.3k, down 188% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SXTP annual revenue was $627.4k, with 111.5% growth year-over-year.

SXTP past revenue growth

How has SXTP's revenue growth performed historically?

Company
111.54%
Industry
499.16%
Market
37.03%
SXTP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SXTP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SXTP's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SXTP revenue history

Current Revenue
$627.4k
Current Earnings
-$7.9M
Current Profit Margin
-1,252.6%

Be the first to know when SXTP announces revenue.

SXTP Revenue History By Year

SXTP Yearly RevenueSXTP RevenueSXTP ChangeSXTP Revenue Growth
2025-12-31$627.40k$330.82k+111.54%
2024-12-31$296.58k$43.01k+16.96%
2023-12-31$253.57k-$257.64k-50.40%
2022-12-31$511.21k-$4.99M-90.71%
2021-12-31$5.50M$3.66M+197.98%
2020-12-31$1.85MN/AN/A

1 of 1

60 Degrees Pharmaceuticals Revenue FAQ

What was SXTP's revenue last quarter?

60 Degrees Pharmaceuticals (NASDAQ: SXTP) reported Q4 2025 revenue of -$465.32 thousand up 313.48% year over year. In the same quarter last year, 60 Degrees Pharmaceuticals's revenue was -$112.54 thousand.

What was 60 Degrees Pharmaceuticals's revenue in 2025?

60 Degrees Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2025 was $627.40 thousand, a 111.54% increase year over year.

How much does 60 Degrees Pharmaceuticals make in a day?

Based on 60 Degrees Pharmaceuticals annual revenue for the past five years, SXTP makes an average of $3,940.21 per day.

What was 60 Degrees Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2026, 60 Degrees Pharmaceuticals's revenue has grown 111.54% year over year. This is 387.62 percentage points lower than the US Biotechnology industry revenue growth rate of 499.16%. 60 Degrees Pharmaceuticals's revenue in the past year totaled $627.40 thousand.

How much does 60 Degrees Pharmaceuticals make in a year?

60 Degrees Pharmaceuticals's revenue by year for the past five years is:
  • 60 Degrees Pharmaceuticals's revenue for the twelve months ending Dec 31, 2025 was $627.40 thousand, a 111.54% increase year over year.
  • 60 Degrees Pharmaceuticals's annual revenue for Dec 31, 2024 was $296.58 thousand, a 16.96% increase from 2023.
  • 60 Degrees Pharmaceuticals's annual revenue for 2023 was $253.57 thousand, a 50.4% decrease from 2022.
  • 60 Degrees Pharmaceuticals's annual revenue for 2022 was $511.21 thousand, a 90.71% decrease from 2021.
  • 60 Degrees Pharmaceuticals's annual revenue for 2021 was $5.50 million, a 197.98% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.